|
EP1350523B1
(en)
|
1992-09-25 |
2007-05-16 |
Boston Scientific Limited |
Therapeutic conjugates inhibiting vascular smooth muscle cells
|
|
IL115766A0
(en)
|
1994-10-25 |
1996-01-19 |
Immulogic Pharma Corp |
Composition and treatment for multiple sclerosis
|
|
US5552524A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US20030044795A1
(en)
|
1996-09-06 |
2003-03-06 |
Inger Byrajalsen |
Biochemical markers of the human endometrium
|
|
US7078375B1
(en)
*
|
1996-10-25 |
2006-07-18 |
Peter Mose Larsen |
Diabetes-mediating proteins and therapeutic uses thereof
|
|
US6329501B1
(en)
|
1997-05-29 |
2001-12-11 |
Auburn University |
Methods and compositions for targeting compounds to muscle
|
|
IL148225A0
(en)
|
1999-09-01 |
2002-09-12 |
Subsidiary No 3 Inc |
Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
|
|
WO2001016323A2
(en)
|
1999-09-01 |
2001-03-08 |
Subsidiary N0.3, Inc. |
Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
|
|
WO2001030973A2
(en)
|
1999-10-25 |
2001-05-03 |
Princeton University |
Genetic sequences associated with neural cell proliferation and disease
|
|
CA2399058A1
(en)
*
|
2000-02-02 |
2001-08-09 |
Transgene S.A. |
Targeting peptides
|
|
WO2004043361A2
(en)
|
2002-11-08 |
2004-05-27 |
Genentech, Inc. |
Compositions and methods for the treatment of natural killer cell related diseases
|
|
US20030203372A1
(en)
|
2000-12-08 |
2003-10-30 |
Ward Neil Raymond |
Analysis method
|
|
US20040236091A1
(en)
|
2001-03-28 |
2004-11-25 |
Chicz Roman M. |
Translational profiling
|
|
US20040058326A1
(en)
|
2001-07-27 |
2004-03-25 |
Brooksbank Robert Alan |
Identification and use of molecules implicated in pain
|
|
US20050191627A1
(en)
|
2001-09-28 |
2005-09-01 |
Incyte Corporation |
Enzymes
|
|
WO2003064501A1
(en)
*
|
2002-01-31 |
2003-08-07 |
Clarke Slemon |
Conformationally restricted compounds as dendrimer cores
|
|
US20050222023A1
(en)
|
2002-02-07 |
2005-10-06 |
Hans-Peter Hauser |
Albumin-fused kunitz domain peptides
|
|
JP2004081111A
(ja)
|
2002-08-27 |
2004-03-18 |
Yamaguchi Technology Licensing Organization Ltd |
虚血性心疾患の治療薬として新規活性を有するα−エノラーゼおよびその利用法
|
|
CN101518533A
(zh)
*
|
2002-12-06 |
2009-09-02 |
法布罗根股份有限公司 |
脂肪调节
|
|
US8124582B2
(en)
|
2002-12-06 |
2012-02-28 |
Fibrogen, Inc. |
Treatment of diabetes
|
|
WO2004055519A2
(en)
|
2002-12-17 |
2004-07-01 |
Sinogenomax Co. Ltd. |
Specific markers for pancreatic cancer
|
|
AU2003300178A1
(en)
|
2002-12-30 |
2004-07-29 |
Ppd Development, Lp |
Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
|
|
WO2004084950A2
(en)
|
2003-03-24 |
2004-10-07 |
Case Western Reserve University |
Cell targeting methods and compositions
|
|
US7473531B1
(en)
|
2003-08-08 |
2009-01-06 |
Colora Corporation |
Pancreatic cancer targets and uses thereof
|
|
WO2005019258A2
(en)
|
2003-08-11 |
2005-03-03 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
JP2005073621A
(ja)
|
2003-09-01 |
2005-03-24 |
Japan Science & Technology Agency |
脳腫瘍マーカーと脳腫瘍の診断方法
|
|
WO2005032572A2
(en)
|
2003-10-03 |
2005-04-14 |
Vib Vzw |
Means and methods for the recruitment and identification of stem cells
|
|
US8133733B2
(en)
|
2003-10-24 |
2012-03-13 |
Gencia Corporation |
Nonviral vectors for delivering polynucleotides to target tissues
|
|
CA2513317A1
(en)
|
2004-07-06 |
2006-01-06 |
Kuhnil Pharmaceutical Co., Ltd. |
Composition for the diagnosis of retinal vascular disease comprising aldolase and method for diagnosis using it
|
|
WO2007046818A2
(en)
|
2004-11-16 |
2007-04-26 |
Board Of Regents, The University Of Texas System |
Compositions and methods related to synchronous selection of homing peptides for multiple tissues by in vivo phage display
|
|
WO2006073254A1
(en)
|
2005-01-03 |
2006-07-13 |
Sook-Yeong Jeon |
Composition for prevention, treatment and diagnosis of chronic inflammatory airway diseases
|
|
US7608413B1
(en)
|
2005-03-25 |
2009-10-27 |
Celera Corporation |
Kidney disease targets and uses thereof
|
|
EP1877099B1
(en)
|
2005-04-06 |
2012-09-19 |
Genzyme Corporation |
Therapeutic conjugates comprising a lysosomal enzyme, polysialic acid and a targeting moiety
|
|
US20070248628A1
(en)
|
2005-12-06 |
2007-10-25 |
Keller Lorraine H |
Immunogens in cancer stem cells
|
|
TWI304443B
(en)
|
2005-12-30 |
2008-12-21 |
Nat Health Research Institutes |
Alpha-enolase specific antibody and method of use
|
|
WO2008012362A2
(en)
|
2006-07-27 |
2008-01-31 |
Oxford Genome Sciences (Uk) Ltd |
New protein isoforms and uses thereof
|
|
ATE542831T1
(de)
|
2006-09-29 |
2012-02-15 |
Ribovax Biotechnologies Sa |
Neue antigene und antikörper, die mit adenokarzinomen des pankreasgangs assoziiert sind
|
|
US20100047256A1
(en)
|
2007-01-25 |
2010-02-25 |
Imperial Innovations Limited |
Methods
|
|
JP2010526091A
(ja)
|
2007-04-30 |
2010-07-29 |
インテザイン テクノロジーズ， インコーポレイテッド |
癌の処置のための生物学的な標的基の改変
|
|
WO2009008727A2
(en)
*
|
2007-07-12 |
2009-01-15 |
Prosensa Technologies B.V. |
Molecules for targeting compounds to various selected organs or tissues
|
|
EP2080812A1
(en)
|
2008-01-18 |
2009-07-22 |
Transmedi SA |
Compositions and methods of detecting post-stop peptides
|
|
JP5429707B2
(ja)
|
2008-03-27 |
2014-02-26 |
国立大学法人群馬大学 |
微粒子およびその製造方法
|
|
WO2009144481A2
(en)
|
2008-05-30 |
2009-12-03 |
Isis Innovation Limited |
Conjugates for delivery of biologically active compounds
|
|
JP2011528557A
(ja)
|
2008-07-18 |
2011-11-24 |
ヒルズ・ペット・ニュートリシャン・インコーポレーテッド |
過体重動物と関連する障害を治療するための組成物および方法
|
|
EP2194382A1
(en)
|
2008-12-03 |
2010-06-09 |
Universität des Saarlandes |
An in-vitro method or assay for detecting a tumor or a cancerous disease by screening for antibodies
|
|
US20110269665A1
(en)
|
2009-06-26 |
2011-11-03 |
Avi Biopharma, Inc. |
Compound and method for treating myotonic dystrophy
|
|
IT1398782B1
(it)
|
2009-09-11 |
2013-03-18 |
Novelli |
Peptide monofosforilato isolato derivato dall'alfa-enolasi umana utile per la diagnosi e il trattamento dell'adenocarcinoma pancreatico, anticorpi diretti contro il suddetto peptide monofosforilato e loro usi.
|
|
WO2011064552A1
(en)
|
2009-11-30 |
2011-06-03 |
Isis Innovation Limited |
Conjugates for delivery of biologically active compounds
|
|
WO2011072290A2
(en)
|
2009-12-11 |
2011-06-16 |
The Regents Of The University Of Michigan |
Targeted dendrimer-drug conjugates
|
|
US20130072437A1
(en)
|
2010-05-28 |
2013-03-21 |
Mind-Nrg Sa |
Neuregulin isoforms,neuregulin polypeptides and uses thereof
|
|
EP2638058B1
(en)
|
2010-11-12 |
2017-01-11 |
Merck Sharp & Dohme Corp. |
Enolase peptide conjugate vaccines against staphylococcus aureus
|
|
JP2014517832A
(ja)
*
|
2011-05-10 |
2014-07-24 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
自己免疫疾患を治療するための方法及び医薬組成物
|
|
GB201113814D0
(en)
|
2011-08-10 |
2011-09-28 |
Proteome Sciences R & D Gmbh & Co Kg |
Materials and methods for determining sensitivity potential of compounds
|
|
CN103998458B
(zh)
|
2011-08-30 |
2018-10-09 |
医学研究理事会 |
具有中央疏水域的细胞穿透肽
|
|
IN2014DN05803A
(cg-RX-API-DMAC7.html)
|
2011-12-14 |
2015-05-15 |
Univ Texas |
|
|
US9921221B2
(en)
|
2012-07-26 |
2018-03-20 |
Joslin Diabetes Center, Inc. |
Predicting and treating diabetic complications
|
|
WO2014070723A1
(en)
|
2012-10-30 |
2014-05-08 |
Particle Sciences, Inc. |
Drug delivery particle formulations with targeting moieties
|
|
AU2015204452A1
(en)
*
|
2014-01-13 |
2016-08-11 |
Berg Llc |
Enolase 1 (Eno1) compositions and uses thereof
|
|
WO2016210008A1
(en)
|
2015-06-22 |
2016-12-29 |
Berg Llc |
Compositions comprising eno1 and their use in methods of treating obesity or overweight and reducing weight gain
|
|
EP3322405A4
(en)
|
2015-07-16 |
2019-01-23 |
Berg LLC |
ENOLASE 1 (ENO1) COMPOSITIONS AND USES THEREOF
|